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http://www.biomedcentral.com/1472-6963/14/318RESEARCH ARTICLE Open AccessUK research funding bodies’ views towards public
participation in health-related research decisions:
an exploratory study
Jennifer E van Bekkum* and Shona HiltonAbstract
Background: A challenge facing science is how to renew and improve its relationship with society. One potential
solution is to ensure that the public are more involved in the scientific process from the inception of research plans
to scientific dissemination strategies. However, to date, little is known about how research funding bodies view
public participation in research funding decisions, and how they involve the public into their strategies and practices.
This paper provides insights into how key representatives working in the UK non-commercial research funding sector
perceive public participation in health-related research funding decisions and the possible implications of these.
Methods: We conducted qualitative semi-structured interviews with 30 key stakeholders from 10 UK non-commercial
research funding bodies that either partially or exclusively fund health-related research. The findings were written up in
thematic narrative form.
Results: The different disciplines that encompass health research, and their differing frames of ‘science and
society’, were found to influence how research funding bodies viewed and implemented public participation in
research funding decisions. Relevant subsets of the public were more likely to be involved in research funding
decisions than lay public, which could be linked to underlying technocratic rationales. Concerns about public
participation stemmed from the highly professionalised scientific environment that the public were exposed to.
Additionally, from a more positivist frame, concerns arose regarding subjective views and values held by the
public that may damage the integrity of science.
Conclusion: Underlying assumptions of technocracy largely appear to be driving PP/PE within the research grant
review process, even in funding bodies that have overtly democratic ideals. Some conceptions of technocracy were
more inclusive than others, welcoming different types of expertise such as patient or research-user experiences and
knowledge, while others suggested taking a narrower and more positivist view of expertise as techno-scientific
expertise. For research to have its maximum impact when translated into healthcare, health policies and health
technologies, there needs to be sensitivity towards multiple frames of knowledge, expertise and underlying values that
exist across science and society.
Keywords: Research funding, Public participation, Public engagement, Public involvement, Health, Decision-makingBackground
Within UK policy, public participation has been pre-
sented as one solution to help renew and improve
society’s trust, interest and relationship with science
[1,2]. In line with previous literature [3], the term public
participation/public engagement (PP/PE) has been used* Correspondence: jennifer.vanbekkum@glasgow.ac.uk
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article, unless otherwise stated.in this paper to refer to deliberative and decision-making
research activities and events that involve members of
the publica. It has been suggested that PP/PE in health re-
search has the potential to improve scientific enquiry,
relevance and quality [4-8], and to enhance the transla-
tion of evidence into practice [9]. A challenge facing
science governance is how to incorporate the public
voice into the ‘front-end’ of science, which in the past
has been exclusively occupied by experts [10]. Increasingly,ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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in their research plans. Holding the ‘purse strings’ to large
amounts of money, funding bodies have the authority to
help shape research processes and practices. This power
has arguably increased in recent years in the UK context,
in part due to political reforms such as the Research Excel-
lence Framework (REF)b and austerity measures that have
decreased researchers’ financial security and increased
pressures to acquire research funding [11].
Research funding bodies in the UK are understood
to carry out PP/PE in a variety of ways to identify and
prioritise health-related research topics, and attribute
different degrees of importance to such processes [12].
Within scientific discourse, different views held about
PP/PE can be linked to ongoing epistemological debates
between positivist approaches (based on empirically-
informed models of inquiry) and post-positivist ap-
proaches to research (emphasising social systems and
subjective values within science) [13]. Respectively, these
approaches generate different modes of knowledge: mode
1 knowledge production stemming from basic research
that is discipline- and investigator-led, and sometimes
termed ‘blue skies’ research; and mode 2 knowledge pro-
duction emanating from applied, multidisciplinary research
that is context- and problem-driven, and grounded in ‘real
life’ [14]. It is mode 2 knowledge that implicitly places
value on the contextual and subjective insights that the
public can bring to research.
There is a strong policy drive for health and medical
research to focus on applied research as a means of fa-
cilitating the translation of scientific discoveries into so-
cietal and economic gains. There are also a number of
powerful incentives stemming from science and technol-
ogy tradition and policy pulling in the opposite direc-
tion, such as the REF (despite its recent inclusion of
impact into the auditing system), the peer review system,
and prestigious academic journals and awards that value
the nature of basic research over applied research [15].
Nevertheless, there is growing consensus recognising the
value of including the public at the early stages of all
types of research, as public knowledge and insights are
understood to facilitate more reflexive and socially-
robust scientific developments [3], regardless of whether
research is basic or applied.
Some research funding bodies have a long history of
involving the public in decision-making and debates
about research [16] and more recently research fun-
ders have embarked on a number of large-scale collab-
orative initiatives to support PP/PE within research. In
2008, the Beacons for Public Engagement initiative was
funded by the UK Higher Education Funding Councils
and the Research Councils UK with support from the
Wellcome Trust, to improve the public engagement cul-
ture in higher education institutions (HEIs). In 2010, theResearch Councils UK in consultation with a host of
non-commercial research funders drew up the Concordat
for Engaging the Public with Research to demonstrate
UK research funders’ support, as well as their public
engagement expectations for HEIs [17]. Following on
from the Beacons imitative, the Research Councils UK
launched the Catalyst project in 2013 to further support
and embed public engagement within the higher education
sector.
In the UK, little research has been carried out in the
non-commercial research funding sector to understand
how PP/PE features within research funding decisions.
While there has been some indication from the health
research funding sector that involving the public at the
front-end of research is valued and important, some
concerns have also been raised about tokenism, where PP/
PE is approached as a tick box exercise [18]. This paper
aims to take an in-depth look at the non-commercial re-
search funding sector in the UK to explore existing views
towards PP/PE in health-related research funding deci-
sions and the possible implications of these.
Methods
We employed qualitative interviews and a constructivist
approach to carry out this research. Qualitative inter-
views were chosen as our data collection method as there
is little published data about the UK research funding
sectors’ views towards PP/PE and we wanted to explore
this topic in some depth. A constructivist approach was
adopted to allow for the potential for plurality of mean-
ings and social realities [19], given the diverse and some-
what contested perspectives and practices of PP/PE that
currently exist in the literature. The research conforms to
RATS guidelines for qualitative research.
Sampling and recruitment
Between autumn 2012 and spring 2013, qualitative in-
depth interviews were conducted with 30 key stake-
holders working for 10 UK non-commercial research
funding bodies that exclusively or partially fund health re-
search. The disciplines of health research these organisa-
tions funded ranged from biomedicine, physical sciences
and engineering to social sciences, public health, and
health services, and varied in type from basic through to
applied research. All of the funding bodies supported vari-
ous forms and degrees of PP/PE within their funded re-
search and their organisation.
The study adopted a purposive sampling strategy to
maximise the representativeness and diversity of UK
non-commercial health research funding bodies involved.
With the input of the study’s advisory groupc, a list of 13
non-commercial UK funding bodies that finance health-
related research was collated. This was by no means
intended as a comprehensive list, but rather a considered
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sector. Of the 13 funding bodies invited to participate in
the study, 10 agreed to take part, one declined due to
time-constraints, one due to a lack of interest in the study,
and one did not respond. This number was deemed suffi-
cient for the study.
Key individuals in each of the organisations were iden-
tified and invited to take part in the study. Commonly,
two individuals from each participating organisation
were identified based upon the role they play within the
organisation: overseeing public engagement activities
(n = 13), or overseeing the research funding process
(n = 10). In addition, the names of research grant review
committee members, all of whom were academics, were
independently searched out through the funding bodies’
websites by the researcher. Where possible, we recruited
one grant review committee member from each of the
participating organisations to take part in an interview
(n = 7). Only a minority of the funding bodies invited to
take part in this study (two out of 10) recruited lay public
to take part in their grant review committees, therefore,
due to a limited sample, public members were not in-
cluded in this specific study.
Interviews
In total, 22 individual interviews and four paired inter-
views (each involving two participants) were carried out
at various sites across England and Scotland. On the re-
quest of a small number of participants, paired inter-
views were carried out with a colleague, who had also
been invited to take part in the study, from the same
funding organisation. Prior to the interviews taking
place, informed participant consent was obtained. It
was made clear to all participants that: their involve-
ment in the study was voluntary; their identity and
their organisation’s identify would remain anonymous
and protected; data would be stored safely; and anon-
ymised data may be used in journal publications, pre-
sentations and workshops. The majority of interviews
were conducted face-to-face (n = 21) at the participants’
workplace or a chosen location, and a small number were
conducted over the telephone (n = 5) for convenience. The
interviews were semi-structured and lasted between 30–
100 minutes, although most were approximately 60 mi-
nutes in length.
The interviews aimed to gain multiple perspectives
from the research funding sector. Three complementary
interview schedules were developed for the three differ-
ent types of participants who took part. The questions
were developed in relation to the study’s aims, with the
help of the advisory group and using the different stages
of the research funding cycle as a chronological frame.
All schedules included some similar core themes and
questions, such as definitions and views about PP/PE,and challenges and successes associated with PP/PE.
Additionally, interviews with participants involved in
PP/PE job roles included questions about their orga-
nisations’ PP/PE strategies, practices and developments.
Interviews with those involved in research funding job
roles included questions about where, if and how PP/PE
is involved in the different research funding aspects. In-
terviews with those holding grant review committee roles
included questions about the makeup and dynamics of
the committee, and how they consider and assess PP/PE
in research funding applications. This study presents
a subset of the data about PP/PE in research funding
decisions.
Data analysis methods
All interviews were recorded, transcribed and checked
for accuracy. Participants’ and research funding orga-
nisations’ names were anonymised and replaced with
individual pseudonyms and codes. Data were themat-
ically analysed and informed by constant comparative
techniques [20] and aspects of situational analysis [21],
both of which stem from grounded theory method-
ology [22,23]. We drew on some of the principles from
situational analysis, such as: an appreciation for know-
ledge as socially and culturally constructed; developing
an awareness of social worlds and competing discourses;
and the use of mapping exercises to aid the analytical
process [21].
Initially the researcher went through each transcript
iteratively to identify an initial coding matrix [20,24],
which was in part informed by the interview schedule as
well as more inductive themes. Comprehensive field-
notes were made throughout the interview and analysis
process. At this stage, a second researcher took part in a
‘depth perception’ exercise [25] aimed to enhance the
primary researcher’s reflexivity towards the data, and in
turn the credibility of the analysis. The exercise involved
the second researcher reading through the codes and a
sample of the transcripts, and asking critical questions
about the content of themes and possible alternative ex-
planations, alongside suggesting text and concepts for
inclusion or exclusion in the analysis. As a result, minor
changes were made to some of the codes and their con-
tent. Next, situational/relational maps and social worlds
maps were created to aid the analysis and the develop-
ment of the overarching themes and discussion, by shift-
ing the focus towards the key discourses, structures and
conditions that characterise the situation of enquiry [21].
Quotes were chosen that exemplified core concepts of
each theme.
For the purposes of qualitative research it is important
to make clear our own views and potential biases toward
this research topic. We understand and support the
ideals of embedding PP/PE in health-related research.
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rying out PP/PE activities, we are also aware and sensitive
to the more pragmatic issues and tensions that translating
such ideals into practice can pose.
Ethics
The ethics application for the study was submitted and
approved by The University of Glasgow College of Social
Sciences Ethics Committee.
Results
The UK non-commercial research funding sector is
made up of a relatively distinctive set of organisations.
Therefore, to ensure anonymity, any quotes included in
this section have been identified by participants’ pseudo-
nyms and roles but not by their affiliated research fund-
ing organisation. Within the research funding process,
participants most commonly discussed the research grant
review committee as a potential PP/PE mechanism for
deliberations and decision-making about research pro-
posals and funding allocation.
An important note to make before discussing the find-
ings is that terminology for public involvement in delib-
erative and decision-making practices (which are the
interest of this paper) differed across participants’ ac-
counts. Some used terms such as public/patient/citizen
involvement or public participation, and others used the
broader term of public engagement.
Conceptions of PP/PE
Across the research funding bodies, participants held
different conceptions about the function of PP/PE within
research generally. Those aligned with applied health
and social sciences research commonly spoke of the im-
portance of actively involving the public perspective in
research decision-making and planning, as their work
often aimed to have relatively direct impact on people’s
lives. For example, one participant from an organisation
that funded significant amounts of applied health research
stated:
I think one of the things that runs very, very, very
strongly throughout the whole of the organisation is
that we do research for patient benefit, and you know
the current, we are very linked into policy. So the
fact that the research we do should be for patient
benefit means you have got to engage with patients
about ‘what do they want, how do they want it?’
(Susan, research funding role).
In contrast, participants aligned more closely with
basic medical and biomedical sciences were likely to
highlight the importance of understanding the public’s
perspectives to develop public advocacy and trust in newresearch. One participant who discussed funding bio-
medical research spoke about his ideas of PP/PE:
Having a research environment that supports science
is favourable. There have been researchers in the past
that haven’t engaged with the debate and it has gone
into the hands of nutters with a particular axe to
grind and the public pick up on mixed messages, you
know, there’s no GM foods in the supermarkets. We
can see the potential pitfalls or risks if we don’t engage
in the debate […] The publics get very concerned
about aspects of science so engaging the debate is
critical. People need to be part of the process of
getting science done and certainly ethical issues if
nothing else (John, research funding role).
On the topic of PP/PE, another participant, whose
organisation funds natural sciences research, discussed
using PP/PE as a kind of marketing tool:
In the end we are a scientific organisation and we have
the say […] And it might, in some cases it might simply
be, say well look at the moment the public aren’t too
keen on this but we think it’s so important to do it that
one of our recommendations is that we engage with the
public in order to try and convince them that it’s a good
thing to do (George, research funding role).
In many cases, participants either explicitly or impli-
citly linked the nature of their research disciplines and
the underlying assumptions to the way in which they
conceptualised PP/PE. One participant affiliated with ap-
plied health research discussed his thoughts about PP/
PE both within and outside the health sector:
We’re talking about a very personal thing [applied
health research]. I think it’s much more embedded […]
you go outside, step outside health research, I, I
mean, I, it’s dismal, really. It’s all about science
literacy, ‘if only the dumb public would’, you know,
‘be a bit better educated and…’ I think there’s a lack
of respect and partnership around the way that a lot
of the rest of science thinks about public
engagement […] and that is because I think the way
that science is run, it’s all around expertise,
hierarchies, it’s generally driven by institutions for
very strong cultures (Paul PP/PE role).
In addition, some participants also related their own
and their funding bodies’ conceptions of PP/PE to other
factors such as: how pro-public key figureheads and
leaders within their organisation were; how proactive in-
dividuals with PP/PE responsibilities were to drive for
change within organisational culture; and how closely
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and the ethos of democracy.
The role of PP/PE in research funding decisions
Many of the participants discussed their funding bodies
having some strategic or advisory input from the public
towards research priority setting or troubleshooting in
their organisations. However, the interview data indi-
cated that within the research funding process only two
funders at the time of the interviews included lay public
within their research grant review committees, two more
had previously included lay publics in their review com-
mittees but ceased to do so, and one presently included
lay public in their external review of grants. Most grant
review committee members and external reviewers were
senior academics or professionals/fellows and those
committees that did include lay public housed one or
two lay members.
Participants whose funding bodies included lay public
or research users in grant review committees funded
significant amounts of applied health or social/public
health research, and spoke of the benefits of having the
public involved in the process as they can: increase the
relevance of research proposals to public life and public
needs; ensure fair play with the allocation of funds; and
add to moral and ethical debates about aspects of re-
search. While these participants commonly discussed
the value of having members of the public on their grant
review committees, they often experienced the public’s
role to be a less active and less empowered one than that
of the ‘expert’. For example, one participant said:
I would say more often than not, actually, they do
make useful contributions. They’re never going to be
a deal breaker in terms of what [whether] our grant is,
I don’t think, supported or not, or not. But they may
have some useful feedback which we would then, the
PI [principle investigator] might have to then clarify.
(Fred, grant review committee).
Some questioned if there was a role for lay public in
the research funding process. For example, one partici-
pant stated:
We’ve been talking a lot about “do you have just a
general member of the public there?” […] I’m coming
to the conclusion that in that kind of high strategic
level, do you need people who represent the, the
public […] who understand public engagement and
understand when it needs to be done […] I almost
think we need that kind of challenge rather than just
having Joe Public sitting within that, because I almost –
I’m not convinced […] that it’s worthwhile for them
(Gina, PP/PE role).Conversely, some did not see a role for the public
within grant review committees as they felt that the pub-
lic did not possess the necessary level of scientific know-
ledge to be able to valuably contribute to the process.
One participant speculated:
I don’t really see there could be a role for them [the
lay public] to be honest. I mean we have a board of
high level experts, we’re assessing high level science
[…] I’m not quite sure what a lay person would do to
be honest apart from be bored to tears and exhausted
by the end of two days […] It’s really overwhelmingly
about the science (Olivia, grant review committee).
One participant spoke of their funding body’s past
experience of involving the public in their grant review
committee:
So we tried to get them involved. And that experiment
didn’t work very well. This is all based on anecdotes of
my predecessor, rather than, you know, corporate
memory as such, but I think that was because they felt
excluded from the process, even though we tried to be
inclusive and all the rest of it (Adam, PP/PE role).
Who are the public?
Participants commonly acknowledged the diverse and
expansive nature of the public using phrases such as
“everyone”, “lay public” or “general public”. They also
commonly recognised the value of segmenting the pub-
lic into more selective sub-groups specific to the type of
PP/PE activity occurring. Across the funding bodies, there
was little consensus about which sub-groups of society
constituted ‘the public’ for PP/PE activities, such as: policy-
makers; industry representatives; practitioners; patients;
carers; non-governmental organisations; and teachers.
Participants affiliated with funding bodies that cur-
rently involve the lay public in grant review committees
explained that the type of lay people the committees
tended to attract normally had an interest in health and
medicine, such as patients with personal insight into a
specific health condition/disease, or retired academics or
professionals. One participant whose funding body did
not include lay public in their research grant committees
spoke of the difficulty of identifying lay public for these
purposes:
[…] how do you select these people? What sort of
range of interests do you want to have? How do they,
how do you stop them becoming inside the tent when
they should be outside the tent really? If you’re not
careful you’ll get some professional people sent you
know […] And then they cease to be representative of
the other man (Kevin, research funding role).
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view committees involving ‘relevant’ subgroups of the
public in their research funding process. These sub-
groups spanned a range of professions that tended to be
either research users (e.g. policymakers, industry, practi-
tioners and non-governmental organisations), or proxies
for a collective public/patient voice (e.g. advocacy groups
and charities). For example, one participant said: “We have
public – some publics with capital P’s – engaged [sitting
on the grant review committees]. So, that’s people from
business and charities and government departments en-
gaged. But that’s not really the same thing as lay people”
(Harry, research funding role). Some participants also
made the case that in certain situations academics that did
not possess expert knowledge within a particular research
area should also be considered a subset of the public, as
they could be considered as lay. For example, one partici-
pant, whose funding body did not involve lay public in
their grant review committees stated:
[…] you know, a quantum physicist is lay when it comes
to, you know, all the different types of other physics
that goes on. Obviously they’ll still have a bit more
background knowledge, and understand the nature of
science, and all that kind of thing (Cara, PP/PE role).
Concerns about PP/PE in research funding decisions
Some participants whose funding bodies did not include
lay public in the grant review process, including some
that in the past did but ceased to, voiced their concerns
about the possibility of the lay public exhibiting emotions,
biases and value-based judgements, especially when dis-
cussing and deciding on technical aspects of research. For
example, one participant expressed their concern that the
public’s lack of scientific knowledge could lead to ‘poor’
decisions.
Well to be blunt, you have to be careful with the
public because on many of our boards and
committees the, you know the science isn’t intelligible
to management. It’s not intelligible to me often. So to
have somebody sitting there who’s not a scientist
looking at grant applications is a complete waste of
time. And not only would they not understand it, but
even if they did understand them I don’t think they
would be particularly helpful in prioritisation […] the
public may regard something else as being very
unimportant and actually it’s extremely important. It
may affect very small numbers of people for example.
So the folks say ‘I won’t bother with that disease any,
you know, only a hundred people a year get it’. But
often that, or you may find that sort of research
actually leads to a better insight about what causes
the disease (Kevin, PP/PE role).These concerns were also discussed, to a lesser degree,
by some of the participants whose funding bodies in-
volved the lay public in their grant review committees.
For example, one participant stated:
The problem is you’re trying not to bring – especially
on the policy side – you’re trying to find someone
that’s not going to bring their own agenda to the table
(sure) you know they’ve got to see the overall picture
[…] you have to be a little bit wary of that I think
sometimes (Eric research funding role).
Some participants, especially those whose funding
bodies involved lay public in their grant review processes,
spoke about ways in which they were trying to support
their lay members within this highly scientific environ-
ment. They discussed offering lay public a range of train-
ing and guidance such as help with deciphering complex
science and jargon, as well as opportunities to attend
relevant conferences and courses. Some also discussed
making ‘public-friendly’ changes to parts of the funding
process such as requiring researchers to write lay research
summaries.
Discussion
An important but under-researched issue that our study
explored was how health-related research funders con-
sidered and included PP/PE in their funding decisions.
For this paper we defined PP/PE as public participation
in deliberations and decision-making processes. The
health-related research funding sector spans a diverse
range of disciplines and, within the bounds of this def-
inition, our findings indicate that participants’ conceptions
of PP/PE in research could be placed on a continuum, such
as that outlined by Kleinman [26], whereby degrees of par-
ticipation range from acknowledging public views, to the
public having an active decision-making role. Involving the
public in research funding decisions appeared to be more
active and embedded within applied health and social re-
search than in basic biomedical and physical sciences.
This is perhaps understandable as in many instances ap-
plied research into health treatments/interventions, ser-
vices and policies is likely to have a more personal and
immediate connection to individuals than more basic
sciences. Other than the nature of research, institutional
factors were also understood to contribute to how individ-
ual funders interpreted PP/PE.
Our study also found that conceptions of the public
within PP/PE activities differed across participants’ ac-
counts. While there was a consensus that the public was
a heterogeneous mass and, therefore, segmenting sub-
groups of the public for specific activities was important,
there was a lack of agreement about which subgroups
constituted the public in PP/PE activities. Although many
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their wider strategic processes via mechanisms such as
public dialogue events, only a small number of funding
bodies involved the lay public in their research grant re-
view committees. Furthermore, those funders who invited
lay members to sit on their committees appeared to attract
a more interested and/or educated subset of the public
than the average man on the street. A more common prac-
tice was to involve selective subgroups of the public such
as professional research-users or proxies for a collective
public/patient voice. Participants indicated that the role of
the public within the research funding process was to in-
crease the practical relevance of research, ensure fair play
in the allocation of funds, and add to moral or ethical de-
bates. However, the public input in this context was often
seen to have less strength than the expert view.
Our findings highlight two common tensions within
the PP/PE literature: public empowerment; and public
representation [27-31]. From a liberal democratic per-
spective that emphasises active public empowerment
and broad public representativeness within decision-
making, our findings indicate that research funding bod-
ies still have considerable ground to cover before PP/PE
in research funding decisions moves beyond tokenistic
engagement. On the other hand, from a technocratic
perspective [32] which focuses on the value that public
expertise (e.g. their knowledge and experience) can add
to research, the breadth of public representation and
their contribution can be legitimately narrower – as the
focus is on the expertise they can supply. Many partici-
pants’ accounts, while at times aligning with democratic
principles, largely embodied a more technocratic ap-
proach to PP/PE in research funding decisions, seeking
to find subsets of the public who could effectively con-
tribute relevant experiential or contextual expertise to
research plans and funding decisions.
Concerns from participants about involving the public
in research funding decisions often related to practical
challenges that they encountered or anticipated. Al-
though some participants welcomed the practical know-
ledge, personal experience and social values that the
public could bring to the research funding process, in
line with previous research [12], we also found numer-
ous and sometimes conflicting concerns about public
knowledge deficits and their biases, emotions and per-
sonal interests potentially damaging the integrity of
science. These concerns appear to stem from more posi-
tivistic technocratic environments and mindsets that
have been long established and protected within science
[33], where decision-making is done by ‘experts’ and
technical language is the accepted norm. Scientific ex-
perts are often empowered by the perception that they
hold ‘desired knowledge’ [34,35]. While the science
knowledge culture is dominant in western societies, thisdoes not automatically qualify the scientific expert view
as the authority or the aspirational public view [36]. It
has long been acknowledged that value-neutral know-
ledge does not exist [37] and that scientists have their
own knowledge deficits [35].
Some participants spoke of the difficulties the scien-
tific environment can pose to the public who enter it.
Those funders who involved lay public in their research
grant review committees also explained some ways in
which they were trying to bridge the expert-lay gap
in research funding decision-making by providing lay
members with training and support, and by requesting
researchers to write lay summaries of their research pro-
posals. However, there was little indication across the
funding bodies involved in our study that mechanisms
for research funding decision-making were significantly
changing to accommodate the public’s needs.
A question to arise from our findings is: should more
democratic principles be adopted within health research
funding bodies’ PP/PE practices? While the ideals of
democracy are attractive, especially for health policy, re-
search and services that have a strong underlying social-
ist ethos, we suggest that the way that research funding
processes are currently set up somewhat limits the possi-
bilities. In the grant review committee, which scrutinises
numerous grant applications often from a wide variety
of research topics and disciplines, even with training and
support it is unlikely that the public would be able to de-
cipher all of the information presented. One of the prob-
lems documented about deliberative methods is that
often the public members will defer to the experts as
they may not have the skills to adequately appraise all of
the information presented, which leads to an unavoid-
able power imbalance [34]. Additionally the nature of the
committee mechanism, which is heavily managed, time-
limited and seats a small number of members, means that
it is unrealistic to accommodate a diverse enough sample
of the public to represent a collective public view [34].
Furthermore, we also suggest that advocating narrow
democratic principles within the research funding decision-
making process could lead to some potential shortfalls.
For instance, in line with some of our participants’ con-
cerns, previous research that explored PP/PE in research
funding concluded that in practice the public may have a
limited role to play in decision-making due to the possible
influence from factors deemed irrelevant, such as the lik-
ability and trustworthiness of the applicants [38]. Litva
[39] suggests that in the health sector, often stakes are
too high to delegate authority to the public, and more so
the public may not care. However, as Martin [32] points
out, failing to strive for more democratic practices of rep-
resentation means that research funding decision-making
neglects the voices of the disinterested public and those
hard-to-reach social groups.
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for PP/PE provides some muddled messages about
which public should be recruited, for what purpose, and
what role they should play in healthcare deliberations
and decision-making, often oscillating between demo-
cratic, technocratic and pragmatic rationales [32]. Our
findings also indicate that the health research funding
sector hosts a variety of mixed and sometimes contradict-
ory views towards the conception, function, and profile
of public involvement in research funding decisions. One
recommendation to come from our research is that fun-
ders and other proponents within the healthcare sector
may benefit from further considering their institutional
conceptions and perspectives of PP/PE. As stated within
the Science For All report [40], it is important to openly
recognise drivers and underlying assumptions of PP/PE.
For those who are currently involving or considering in-
volving the public in research funding decisions, it may
be helpful to ensure that PP/PE mechanisms match their
intended function. For example, Rowe and Frewer [41]
have produced a typology of engagement mechanisms in
relation to the functions of public communication, con-
sultation and participation. Design protocols can also be
found within the literature such as Bryson and colleagues
[42] evidence-based guidelines for designing public par-
ticipation activities, which examines the context and pur-
pose of the PP/PE activities, the resources needed to
manage participation, and evaluation.
An additional recommendation to come from our
findings is for funders to further consider and clarify
what qualities they are looking for in the public they
recruit to help them with decision-making practices
in relation to their institutional perspective of PP/PE.
Martin [32] suggests that healthcare organisations are
looking for a new conception of the public that tran-
scends democratic and technocratic notions, and that
can mediate between science and society, describing this
conception of the public as an “expert of laity” who has an
interest in health, an understanding of community needs
and views, and enthusiasm to make a difference. Similarly,
one participant from our study considered searching for a
sort of expert who understands when public engagement
is needed: a middle man of sorts, who can gauge the needs
of the research and the needs of the public. Some funders
may already be recruiting such a person, as some partici-
pants discussed involving charity or advocacy group repre-
sentatives, or practitioners who can provide an informed
overview of specific communities. A middle man might
also come in the form of a community engagement expert
or a public engagement consultant.
A final recommendation stemming from our findings
is that scientific and professional experts, and funding
staff who make up a large percentage of these commit-
tees, may benefit from being more reflexive, questioningtheir own values and knowledge in light of different
frames. Grant review committees provide valuable op-
portunities to learn not only from the public but also
from other sub-disciplines of science. Some scholars
would go as far as to argue that the very subjective
judgements, emotion and biases that concerned our par-
ticipants can provide the most fruitful opportunities for
learning [43].
Strengths and limitations
The present study has a number of strengths, such as
the novel and in-depth nature of the exploratory re-
search. However, the findings should be interpreted with
some caution due to a series of factors. As a conse-
quence of using both individual and paired interviews,
there is a possibility that the answers provided may be of
differing quality. For example, those participants who
were interviewed in pairs may not have spoken as openly
due to the presence of a colleague. There is also the pos-
sibility that colleagues who have a good rapport, which
seemed to be the case with all of the paired interviews
carried out, may feel more comfortable, relaxed and pre-
pared to speak openly. Participants’ accounts presented
in this research may not necessarily provide an accurate
or comprehensive representation of their associated re-
search funding bodies’ views and values. In an effort to
address this limitation, where possible, we interviewed
two or more members of staff from each organisation.
The small-scale qualitative nature of the study, while
providing a rich and nuanced picture, infers limited em-
pirical generalisability of the findings; therefore, they
should be interpreted in context. Finally, it is important
to acknowledge that interview data taken from one time
point can only provide a static snapshot, and that some
of the PP/PE policies and practices discussed may have
been changed or updated by the time of publication.
Conclusion
The different research disciplines that straddle health,
and their differing frames of ‘science and society’ and
‘expert and lay’, were found to influence how research
funding bodies viewed and implemented PP/PE in re-
search funding decisions. Underlying assumptions of
technocracy largely appear to be driving PP/PE within
the research grant review process, even in funding bodies
that have overtly democratic ideals. Some conceptions of
technocracy were more inclusive than others, welcoming
different types of expertise such as patient or research-
user experiences and knowledge, while others suggested
taking a narrower and more positivist view of expertise as
techno-scientific expertise. Although it may not necessar-
ily be that feasible to accommodate ‘all’ public voices in
the research funding process, in an increasingly multidis-
ciplinary and collaborative research climate it is important
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sideration of what constitutes knowledge and expertise.
For research to have its maximum impact when translated
into healthcare, health policies and health technologies,
there needs to be sensitivity towards multiple frames of
knowledge, expertise and underlying values that exist
across science and society.
Endnotes
aThis term, PP/PE, was chosen as deliberation and
decision-making can fall within definitions of both public
participation (PP) and public engagement (PE). We ac-
knowledge that the term public engagement has broad
connotations that range from information provision to
decision-making activities. However, we have tried to keep
the focus of this paper oriented to more active forms of
public deliberation and participation in research practices
and processes.
bThe Research Excellence Framework is the system in
the UK that is used by higher education funding bodies
to assess the quality of research in higher education intui-
tions (http://www.ref.ac.uk).
cAt the beginning of the research project an advisory
group was set up to help guide and provide feedback
throughout the design, development and execution of
the research project. The group was made up of individ-
uals who had expert knowledge and insights into public
engagement with research. The group comprised four
members: two research funding body personnel; one
academic; and one head of a public engagement advo-
cacy organisation. We felt it was of importance for the
project to have members of the group who were working
directly in the research funding sector, so that we were
able to ensure the study was not just of academic rele-
vance but that it was also grounded in practice.
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